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Purpose: Single nucleotide polymorphisms (SNPs) rs1048661 (p.R141L) and rs3825942 (p.G153D) in the lysyl oxidase-
like 1 (LOXL1) gene have been previously reported to be associated with pseudoexfoliation glaucoma (PEXG) in various
Asian and European populations, but these SNPs have not yet been studied in the Pakistani population. Therefore the aim
of the present study was to investigate the association of these two coding LOXL1 SNPs in Pakistani PEXG patients.
Methods: One hundred twenty-eight Pakistani patients diagnosed with PEXG and 180 healthy controls were recruited
for the study. Genomic DNA was extracted and both SNPs were genotyped by direct sequencing. Association of genotype
and allele frequencies with PEXG were analyzed using the Chi-square (χ2) test.
Results: Genotype and allele frequencies of both rs1048661 and rs3825942 were found to be significantly associated with
PEXG. The GG genotypes of both LOXL1 SNPs were associated with an increased risk of developing PEXG. In addition
the G alleles of rs1048661 and rs3825942 confer an increased risk for PEXG with an odds ratio (OR) of 2.98 (95% CI
1.94–4.57) and OR 6.83 (95% CI 2.94–16.67), respectively.
Conclusions: A significant association was found for the G allele of rs1048661 and rs3825942 in PEXG patients of
Pakistani origin.
Pseudoexfoliative glaucoma (PEXG) occurs when
pigment and abnormal basement membrane material from the
anterior segment of the eye deposit in the trabecular meshwork
(TM), which raises the intraocular pressure of the eye causing
a degeneration of the optic nerve. In addition the presence of
pseudoexfoliative material causes changes in the cornea,
camerular angle, lens and zonules as well as a significant loss
in the number of axons [1,2]. The accumulation of exfoliative
material in the juxtacanalicular tissue (JCT) results in the
disorganization of the JCT and Schlemm’s canal followed by
dysfunction of endothelial cells, which appear to be the
causative factor in the development of PEXG [3].
The precise etiology and pathogenesis of
pseudoexfoliative glaucoma still remains unknown. Previous
molecular, biochemical and immunohistochemical studies
have elucidated that proteins of the extracellular matrix
(ECM), metabolism and cellular stress are differentially
expressed in tissues of PEXG patients. It has been observed
that the pathophysiology of PEXG involves an excessive
production of elastic microfibrillar components, changes in
the enzymatic cross linking processes, a proteolytic imbalance
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between matrix metalloproteinases and their inhibitors. It is
also conceivable that lack of antioxidants and increased
cellular and oxidative stress may play an important role in the
progression of PEXG as a stress-induced elastic
microfibrillopathy [4,5]. A family of five lysyl oxidase
enzymes (LOX, LOXL1, LOXL2, LOXL3, and LOXL4) play
an important role in cross-linking between collagen, elastin
and fibrillin, which are the substrates of the LOXL1 enzymes
in the connective tissues. This cross-linking reaction provides
additional mechanical strength to the ECM and makes it more
resistant to degradation [6]. It has been reported in a recent
study that greater cross linking in the tissues of TM and ECM
makes the tissues stiffer in glaucomatous eyes as compared to
the non-glaucomatous eyes [7]. LOXL1 expression is
enhanced in the TM by the cytokine tumor growth factor beta1
(TGF β1). This changes the cross linking ability of LOXL1 in
PEXG, which results in the deposition of exfoliative material
and increased resistance in the aqueous outflow pathway [8].
A recent genome-wide association study in PEXG
patients from Iceland and Sweden identified a strong
association with two non-synonymous polymorphisms in
LOXL1 [9]. Similarly in German and Italian populations a
strong association has been observed between PEXG and
polymorphisms in LOXL1, which support an important role
of this gene in the progression of PEXG in various populations
[10]. In a meta-analysis of LOXL1 polymorphisms in different
populations including Caucasian, Japanese, Indian, and
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Chinese it has been observed that the G allele of rs3825942 is
a common disease associated allele, with an overall odds ratio
of 10.89 (95% CI 7.20–16.45). However, only in the
Caucasians case the G allele of rs1048661 was found to impart
an increased risk to the disease (OR 2.35) while in the
Japanese population the G allele was found to have a highly
protective role (OR 0.03). In the Chinese and Indian
populations this polymorphism was not found to be
significantly associated with PEXG [11].
Although single nucleotide polymorphisms (SNPs) in
LOXL1 have been studied in many populations, an analysis of
PEXG patients from Pakistan had not yet been performed.
Therefore the aim of the present study was to analyze the two
non-synonymous polymorphisms (rs1048661 and
rs3825942) in LOXL1 in PEXG patients from Pakistan.
METHODS
Patients: The present case control study included 128 patients
diagnosed with PEXG and 180 healthy controls of Pakistani
origin who were recruited from the Al-Shifa Eye Trust
Hospital in Rawalpindi, Pakistan. Complete ophthalmic
examinations were performed for both patients and controls
as reported previously [12]. Briefly, clinical evaluation of
patients included measurement of cup-to-disk ratio, intra-
ocular pressure and slit lamp biomicroscopy to detect the
presence of exfoliative material. PEXG was diagnosed in
patients who presented with an accumulation of microfibrillar
deposits or exfoliative material on the papillary ruff, a clear
annular zone, or flakes of exfoliative material with a grayish
central disc on the anterior lens capsule, iris, or corneal
endothelium in one or both eyes. Controls and cases were
matched for age, gender and ethnicity (Punjabi).
Genomic DNA and genotyping: The current study was
approved by the institutional review board of the Al-Shifa Eye
Trust Hospital, Rawalpindi, Pakistan, and adhered to the
tenants of the Declaration of Helsinki. Whole blood samples
of both patients and controls were drawn by venipuncture after
obtaining informed written consent. The blood samples were
collected in EDTA vacutainer tubes (Becton Dickinson,
Franklin Lakes, NJ) and stored at 4 °C till further processing.
Genomic DNA was obtained from the whole blood using a
standard phenol chloroform method [13].
Genomic DNA was genotyped for two non-synonymous
SNPs located in exon 1 of LOXL1: rs1048661 (c.758G>T;
p.Arg141Leu) and rs3825942 (c.794G>A; p.Gly153Asp).
The following primers were used to amplify a 259 bp product,
which spans both the polymorphic sites in exon 1 of LOXL1:
forward primer 5′-ATT CGG CTT TGG CCA GGT GC-3′ and
reverse primer 5′ GTA CAC GAA ACC CTG GTC GT-3′.
The polymerase chain reaction (PCR) mixture contained 2.5U
Taq polymerase (Roche, Mannheim, Germany), 1× PCR
buffer, 1.5 mM MgCl2, 10 µM each primer and 50 ng genomic
DNA. PCR amplification was performed with an initial
denaturation at 95 °C for 5 min, followed by 35 cycles of
denaturation at 95 °C for 45 s, primer annealing at 65 °C for
45 s, extension at 72 °C for 45 s, followed by a final extension
for 7 min at 72 °C. PCR products were separated on a 2%
agarose gel and purified using PCR clean-up purification
plates (NucleoFast® 96 PCR; Macherey-Nagel, Duren,
Germany), according to the manufacturer’s protocol. Purified
PCR products were analyzed by Sanger sequencing using an
automated DNA sequencer (Big Dye Terminator chemistry,
version 3 on a 3730 DNA analyzer; Applied Biosystems, Inc.,
Foster City, CA).
Statistical analysis: Data were analyzed using the SPSS
statistical package (SPSS version 16.0; SPSS, Chicago, IL).
Odds ratios (OR) for genotype and allele frequencies of
patients compared to controls were calculated using the Chi-
square (χ2) test, taking a 95% confidence interval (95% CI)
into account. A p-value <0.05 was considered as statistically
significant.
RESULTS
All PEXG patients and control individuals originated from the
Punjab province of Pakistan. The PEXG patients had a mean
age of 47.3±10.3 years and included 54% males and 46%
females, whereas the controls had a mean age of 45.2±10.8
years with 52% males and 48% females.
The distribution of the LOXL1 genotype and allele
frequencies of SNPs rs1048661 and rs3825942 were analyzed
in PEXG patients and control individuals. Figure 1 shows the
normal, heterozygous and homozygous variant sequences for
the two SNPs studied. The genotype frequencies were
consistent with the Hardy–Weinberg equilibrium (HWE) for
both SNPs in the controls. Table 1 gives the detailed count of
the genotype and allele frequencies of rs1048661 and
rs3825942 polymorphisms of LOXL1. For both SNPs a
significant association was identified for the genotype (p-
value <0.001) and allele frequencies (p-value <0.001) in
PEXG patients as compared to controls. The G allele of
rs1048661 was found in 85.2% of the patient alleles compared
to 65.8% of control alleles, demonstrating that it confers an
increased risk for PEXG (OR 2.98 [95% CI 1.94–4.57]). The
G allele of rs3825942 had an even stronger association with
PEXG, as it was found in 97.3% of patient alleles compared
to 83.9% of control alleles (OR 6.83 [95% CI 2.94–16.67]).
DISCUSSION
SNPs in LOXL1 have previously been associated with PEXG
in various European and Asian populations, to date these have
not been studied in the Pakistani population. The current study
is the first to demonstrate that LOXL1 SNPs are associated
with PEXG patients from Pakistan. The highest association
was observed with the G allele of rs3825942 (OR 6.83), which
was present in an overwhelming majority of the cases with
PEXG. A significant but lower association was also noted
with the G allele of rs1048661 (OR 2.98).
Molecular Vision 2012; 18:1040-1044 <http://www.molvis.org/molvis/v18/a110> © 2012 Molecular Vision
1041
A recent meta analysis of several studies from different
populations demonstrated a strong association between PEXG
and the G allele of SNP rs3825942 in Caucasian and Asian
populations (overall OR 10.89), while the G allele of SNP
rs1048661 was found to confer an increased risk in only the
Caucasian populations (OR 2.35), whereas in the Japanese
population it has a protective role (OR 0.03). This suggests
that rs1048661 is not directly implicated in the disease
etiology of PEXG. It is more likely that rs3825942 is the
common disease-associated polymorphism and may have
functional impacts on the LOXL1 protein [11]. This is in line
with our findings in the Pakistani population as we found a
higher OR (6.83) for rs3825942 as compared to rs1048661
(2.98). Similar results were obtained in recent studies of Latin
American and Uygur populations, which were not included in
the meta analysis of LOXL1 polymorphisms [14,15].
Not surprisingly our results differ from those reported in
the Indian population; the G-allele of the rs1048661
polymorphism was found less frequently in Indian cases and
controls (allele frequencies of 72.1% and 63.4%, respectively)
and was not found to be significantly associated with PEXG
[16]. The allele frequencies in our Pakistani cases and controls
(85.2% and 65.8%, respectively) resembled more closely the
frequencies in American and European cohorts, rather than
Figure 1. Sequence chromatograms of
the two LOXL1 SNPs of Exon 1. A-C:
The corresponding normal (GG),
heterozygous (GT), and homozygous
variant (TT) sequences for rs1048661.
D-F: Normal (GG), heterozygous (GA),
and homozygous variant (AA)
sequences for rs3825942.
TABLE 1. LOXL1 SNPS GENOTYPE AND ALLELE FREQUENCIES IN PEXG PATIENTS AND CONTROLS.
rs1048661 G/T Controls n=180 (%) PEXG n=128 (%) p-value p-value OR (95% CI)
GG 78 (43.3) 91 (71.1)                                       
GT 81 (45.0) 36 (28.1) 0.00000064 0.0001 2.63 (1.55–4.45)
TT 21 (11.7) 1 (0.80) 0.00001 24.50 (3.37–500)
Alleles
G 237 (65.8) 218 (85.2)                      0.0000001                      2.98 (1.94–4.57)
T 123 (34.2) 38 (14.8)
rs3825942 G/A Controls n=180 (%) PEXG n=128 (%) p-value p-value OR (95% CI)
GG 130 (72.2) 121 (94.5)                                       
GA 42 (23.3) 7 (5.50) 0.000003 0.00001 5.58 (2.30–14.19)
AA 8 (4.5) 0 (0.00) 0.007 (N/A)
Alleles
G 302 (83.90) 249 (97.3)                       0.0000001                    6.83 (2.94–16.67)
A 58 (16.10) 7 (2.70)
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the Indian population, which is in agreement with our
population genetics data where we see a cline passing through
Pakistan and diminishing in intensity toward India [17-19].
The frequency of the G-allele of rs3825942 in Indian patients
and controls (92.3% and 74.2%, respectively) was also
somewhat lower than in our Pakistani cohorts (97.5% in
PEXG and 83.9% in controls), and the OR was slightly lower
in the Indian cohort (4.17) compared to our Pakistani cohort
(6.98). The lower association of rs3825842 in the Indian and
Pakistani populations compared to other populations from
America, Europe and Asia (overall OR 10.89), suggests that
additional genetic factors may play a role in PEXG in India
and Pakistan, either within the LOXL1 or in other genes. This
is supported by a recent study demonstrating that neither
rs1048661 (R141L) nor rs3825942 (G153D) affect the amine
oxidase activity of LOXL1, suggesting that other unknown
genetic factors or molecular mechanisms may be more
relevant to the development of PEXG [20].
In previous studies we have identified significant
associations with polymorphisms in the glutathione S-
transferase (GSTT1 and GSTM1) [21] and tumor necrosis
factor alpha (TNF-α) [12] with PEXG. Among these higher
OR was observed for TNF-α (8.37) as compared to LOXL1
(6.98), GSTT1 (4.26), and GSTM1 (3.81), the combined effect
of all these genes probably have a significant contribution in
causing PEXG in the Pakistani cohort. The present study
confirms the involvement of the two LOXL1 coding
polymorphisms in PEXG in the Pakistani population. Further
studies at the functional level are required to better understand
the involvement of LOXL1, glutathione S-transferase and
tumor necrosis factor alpha in PEXG, which could potentially
aid the development of therapeutic approaches for the disease.
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